Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects
Clinical trial NCT01934153 · COMPLETED
Trial details
- NCT number
- NCT01934153
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-02
- Primary completion
- 2014-02-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.